Myocardial Reperfusion Injury
作者： Derek M. Yellon , Derek J. Hausenloy
DOI: 10.1056/NEJMRA071667
关键词:
摘要: Lethal reperfusion injury is a paradoxical type of myocardial caused by the restoration coronary blood flow after an ischemic episode. This review focuses on mechanisms injury, attempts to protect heart against it, and promising new approaches cardioprotection during percutaneous intervention.
pubmed.cn参考文章(95)
Giuseppe Patti, Vincenzo Pasceri, Giuseppe Colonna, Marco Miglionico, Dionigi Fischetti, Gennaro Sardella, Antonio Montinaro, Germano Di Sciascio, Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. Journal of the American College of Cardiology. ,vol. 49, pp. 1272- 1278 ,(2007) , 10.1016/J.JACC.2007.02.025
J. J. Lemasters, J. M. Bond, E. Chacon, I. S. Harper, S. H. Kaplan, H. Ohata, D. R. Trollinger, B. Herman, W. E. Cascio, The pH paradox in ischemia-reperfusion injury to cardiac myocytes EXS. ,vol. 76, pp. 99- 114 ,(1996) , 10.1007/978-3-0348-8988-9_7
J L Zweier, Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. Journal of Biological Chemistry. ,vol. 263, pp. 1353- 1357 ,(1988) , 10.1016/S0021-9258(19)57309-4
E J Griffiths, A P Halestrap, Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochemical Journal. ,vol. 307, pp. 93- 98 ,(1995) , 10.1042/BJ3070093
Roberto Bolli, Eduardo Marbán, Molecular and Cellular Mechanisms of Myocardial Stunning Physiological Reviews. ,vol. 79, pp. 609- 634 ,(1999) , 10.1152/PHYSREV.1999.79.2.609
Paul W. Armstrong, Christopher B. Granger, Pexelizumab and the APEX AMI trial. JAMA. ,vol. 297, pp. 1881- 1882 ,(2007) , 10.1001/JAMA.297.17.1881-B
Derek J Hausenloy, Michael R Duchen, Derek M Yellon, Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia–reperfusion injury Cardiovascular Research. ,vol. 60, pp. 617- 625 ,(2003) , 10.1016/J.CARDIORES.2003.09.025
Lazaros A. Nikolaidis, Sunil Mankad, George G. Sokos, Glen Miske, Ankur Shah, Dariush Elahi, Richard P. Shannon, Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion Circulation. ,vol. 109, pp. 962- 965 ,(2004) , 10.1161/01.CIR.0000120505.91348.58
Carl W. Christensen, Michelle A. Rieder, Eve L. Silverstein, Nelson E. Gencheff, Magnesium Sulfate Reduces Myocardial Infarct Size When Administered Before but Not After Coronary Reperfusion in a Canine Model Circulation. ,vol. 92, pp. 2617- 2621 ,(1995) , 10.1161/01.CIR.92.9.2617
Xi-Ming Yang, Sebastian Philipp, James M. Downey, Michael V. Cohen, Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Research in Cardiology. ,vol. 101, pp. 311- 318 ,(2006) , 10.1007/S00395-006-0587-2